Detailed Information

Cited 0 time in webofscience Cited 9 time in scopus
Metadata Downloads

Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric canceropen access

Authors
Chang, Hae RyungNam, SeungyoonLee, JinhyukKim, Jin-HeeJung, Hae RimPark, Hee SeoPark, SungjinAhn, Young ZooHuh, IksooBalch, CurtKu, Ja-LokPowis, GarthPark, TaesungJeong, Jin-HyunKim, Yon Hui
Issue Date
Dec-2016
Publisher
IMPACT JOURNALS LLC
Keywords
gastric cancer; RHOA; G-protein; biomarker; therapeutic target
Citation
ONCOTARGET, v.7, no.49, pp 81435 - 81451
Pages
17
Journal Title
ONCOTARGET
Volume
7
Number
49
Start Page
81435
End Page
81451
URI
https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/9344
DOI
10.18632/oncotarget.12963
ISSN
1949-2553
1949-2553
Abstract
Gastric cancer (GC) is a highly heterogeneous disease, in dire need of specific, biomarker-driven cancer therapies. While the accumulation of cancer "Big Data" has propelled the search for novel molecular targets for GC, its specific subpathway and cellular functions vary from patient to patient. In particular, mutations in the small GTPase gene RHOA have been identified in recent genome-wide sequencing of GC tumors. Moreover, protein overexpression of RHOA was reported in Chinese populations, while RHOA mutations were found in Caucasian GC tumors. To develop evidence-based precision medicine for heterogeneous cancers, we established a systematic approach to integrate transcriptomic and genomic data. Predicted signaling subpathways were then laboratory-validated both in vitro and in vivo, resulting in the identification of new candidate therapeutic targets. Here, we show: i) differences in RHOA expression patterns, and its pathway activity, between Asian and Caucasian GC tumors; ii) in vitro and in vivo perturbed RHOA expression inhibits GC cell growth in high RHOA-expressing cell lines; iii) inverse correlation between RHOA and RHOB expression; and iv) an innovative small molecule design strategy for RHOA inhibitors. In summary, RHOA, and its oncogenic signaling pathway, represent a strong biomarker-driven therapeutic target for Asian GC. This comprehensive strategy represents a promising approach for the development of "hit" compounds.
Files in This Item
Go to Link
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE